Performance evaluation of serum PIVKA‐II measurement using HISCL‐5000 and a method comparison of HISCL‐5000, LUMIPULSE G1200, and ARCHITECT i2000

BACKGROUND: Protein induced by vitamin K antagonist‐II (PIVKA‐II), in addition to alpha‐fetoprotein, is a useful tumor marker for diagnosis of hepatocellular carcinoma (HCC). We evaluated the analytical performance of the HISCL‐5000 analyzer (Sysmex Corporation) in the measurement of serum PIVKA‐II....

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Mi Ra, Kang, Eun‐Suk, Park, Hyung‐Doo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642327/
https://www.ncbi.nlm.nih.gov/pubmed/31131509
http://dx.doi.org/10.1002/jcla.22921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642327/
https://www.ncbi.nlm.nih.gov/pubmed/31131509
http://dx.doi.org/10.1002/jcla.22921

Ejemplares similares